JPH01151524A - 'satotsu-ko' poultice and preparation thereof - Google Patents
'satotsu-ko' poultice and preparation thereofInfo
- Publication number
- JPH01151524A JPH01151524A JP63284592A JP28459288A JPH01151524A JP H01151524 A JPH01151524 A JP H01151524A JP 63284592 A JP63284592 A JP 63284592A JP 28459288 A JP28459288 A JP 28459288A JP H01151524 A JPH01151524 A JP H01151524A
- Authority
- JP
- Japan
- Prior art keywords
- parts
- plaster
- patch
- chinese herbal
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title description 5
- 239000011505 plaster Substances 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 12
- 239000008159 sesame oil Substances 0.000 claims abstract description 11
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 11
- 229920003051 synthetic elastomer Polymers 0.000 claims abstract description 9
- 239000005061 synthetic rubber Substances 0.000 claims abstract description 9
- 229920003052 natural elastomer Polymers 0.000 claims abstract description 8
- 229920001194 natural rubber Polymers 0.000 claims abstract description 8
- 239000004094 surface-active agent Substances 0.000 claims abstract description 7
- 244000043261 Hevea brasiliensis Species 0.000 claims abstract 4
- 241000411851 herbal medicine Species 0.000 claims description 13
- 239000004615 ingredient Substances 0.000 claims description 12
- 235000015277 pork Nutrition 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 229940079593 drug Drugs 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 9
- 229920001971 elastomer Polymers 0.000 abstract description 6
- 239000005060 rubber Substances 0.000 abstract description 6
- 235000010418 carrageenan Nutrition 0.000 abstract description 4
- 239000000679 carrageenan Substances 0.000 abstract description 4
- 229920001525 carrageenan Polymers 0.000 abstract description 4
- 229940113118 carrageenan Drugs 0.000 abstract description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 abstract description 4
- 235000013871 bee wax Nutrition 0.000 abstract description 3
- 239000012166 beeswax Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000003390 Chinese drug Substances 0.000 abstract 1
- 239000010426 asphalt Substances 0.000 abstract 1
- YFGAFXCSLUUJRG-WCCKRBBISA-M sodium;(2s)-2-amino-5-(diaminomethylideneamino)pentanoate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCCN=C(N)N YFGAFXCSLUUJRG-WCCKRBBISA-M 0.000 abstract 1
- 239000002585 base Substances 0.000 description 21
- -1 polyoxyethylene Polymers 0.000 description 14
- 238000002156 mixing Methods 0.000 description 10
- 239000004744 fabric Substances 0.000 description 8
- 239000002674 ointment Substances 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 235000010413 sodium alginate Nutrition 0.000 description 4
- 239000000661 sodium alginate Substances 0.000 description 4
- 229940005550 sodium alginate Drugs 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920001083 polybutene Polymers 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000010985 glycerol esters of wood rosin Nutrition 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229920006173 natural rubber latex Polymers 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は左突膏の組成物を含有する貼付剤及びその製造
法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a patch containing a composition of left plaster and a method for producing the same.
左突膏は古来より外用漢方処方の一つとして知られてお
り2種々の疾患の治療に用いられている。すなわち、左
突膏はゴマ油1,000部、 黄ロウ220部、豚、脂
5!3部及び瀝膏800を処方成分とし、化膿性のはれ
もの等の治療に有効である。Left ointment has been known as one of the Chinese herbal medicines for external use since ancient times, and is used to treat a variety of diseases. In other words, the left-hand plaster contains 1,000 parts of sesame oil, 220 parts of yellow wax, 5.3 parts of pork fat, and 800 parts of plaster, and is effective in treating purulent swelling.
漢方製剤としての左突膏は従来そのまま皮膚に塗布する
か、あるいは基布に塗布し、これを患部に当てる剤形と
して使用に供されている。As a Chinese herbal medicine preparation, Zuo-tou-yun has conventionally been used in the form of a dosage form that is applied directly to the skin or applied to a base cloth and then applied to the affected area.
しかしながら、かかる軟膏形態の左突膏の製剤は
+11 使用時、軟膏、あるいはそれを塗布した基布
の裏面から有色油状の液体が滲出し、肌や衣類を着色汚
染し、その汚染は洗浄しても容易におちない
(2) 基布に対して塗布性が悪(、軟膏の一定量を
均一な厚さに塗布できない
(3) 冬期軟膏が固化し易く、基布は勿論皮膚に対
しても展延性が悪く充分展延して塗布しにくい
(4) 使用終了後、軟膏が肌面に残留し、拭きとる
こともできない
など、実用上程々の難点があり、上記効用に優れている
にも拘らず、従来繁用されるまでに至らなかったのが実
情である。However, such ointment formulations are +11. When used, a colored oily liquid oozes out from the back side of the ointment or the base fabric on which it is applied, staining the skin and clothing, and the contamination can be removed by washing. (2) Poor applicability to the base fabric (cannot apply a certain amount of ointment to a uniform thickness (3) Winter ointment tends to solidify and is difficult to apply to the base fabric as well as the skin. The ointment has poor spreadability and is difficult to spread sufficiently and apply. However, the reality is that it has not come into widespread use.
本発明者らはかかる技術水準下に、従来鎮痛消炎の目的
で使用されているパップ剤の剤形で有色油状物の滲出が
あるか否かについて研究するため9日本薬局方収載のカ
オリンパップに用いられている基剤と左突膏とを種々の
配合比で配合して試作したところ、かかる配合にあって
はいずれも膏体が均一に練合せず大量の油性成分が液状
のまま残り、保形性ある膏体な得ることさえできないこ
とが判明した。Based on the above state of the art, the present inventors investigated whether colored oil exudates in the form of poultices conventionally used for the purpose of analgesic and anti-inflammatory purposes. When trial production was carried out by mixing the used base and left plaster in various ratios, it was found that in all such combinations, the paste was not evenly kneaded and a large amount of oily components remained in liquid form. It turned out that it was not even possible to obtain a shape-retaining plaster.
しかも、左突膏に用いられる油性成分殊に豚脂は酸敗さ
れ易く、経時的に特有の異臭を放つなど安定性にも問題
があることも判明した。Moreover, it has been found that the oily components, especially the pork fat, used in left bulges are prone to rancidity and have stability problems, such as emitting a peculiar odor over time.
古来より幾多の臨床経験を経て確立された漢方処方をそ
のまま生かし、かつ前述の難点を克服した製剤の提供を
目的として更に追求した結果、意外にもアルギン酸ナト
リウム、カルボキシメチルセルロースナトリウム、ポリ
アクリル酸ナトリウム、カラギナン、カルボキシメチル
セルロース、メチルビニルエーテル無水マレイン酸コポ
リマー等の親水性高分子、天然又は合成ゴムあるいはこ
れらの混合物や、これらに更に界面活性剤を配した貼付
基剤を用いるとき。As a result of our further pursuit to provide a formulation that overcomes the above-mentioned difficulties while making full use of Chinese herbal formulas established through numerous clinical experiences since ancient times, we unexpectedly discovered sodium alginate, sodium carboxymethyl cellulose, sodium polyacrylate, When using a hydrophilic polymer such as carrageenan, carboxymethyl cellulose, methyl vinyl ether maleic anhydride copolymer, natural or synthetic rubber, or a mixture thereof, or a patch base containing a surfactant in addition to these.
左突膏の薬効を損うことなく、漢方処方左突膏の組成物
を均一に混和した高粘性で保形性に優れたゲルが形成さ
れ、有色油性成分の滲出が抑制されることを知見して本
発明を完成するに至った。It was discovered that a gel with high viscosity and excellent shape retention was formed by uniformly mixing the composition of the Chinese herbal medicine prescription Zuobutsu, without impairing the medicinal efficacy of the leftobutsu, and the exudation of colored oily components was suppressed. As a result, the present invention was completed.
本発明は左突膏をパップ剤の形態とした点で全く新規で
あり、従来の左突膏の欠点を悉く解消した製剤を提供で
きた点で画期的である。The present invention is completely new in that it uses left plaster in the form of a poultice, and is groundbreaking in that it can provide a preparation that eliminates all the drawbacks of conventional left plaster.
すなわち9本発明によって提供される左突膏の貼付剤は
、その膏体面や基布裏面からの有色油状物の滲出がなく
、保水性、粘弾性、剥離性。In other words, the left plaster patch provided by the present invention does not exude colored oil from the plaster surface or the back surface of the base fabric, and has water retention, viscoelasticity, and peelability.
安定性に優れ、主薬成分の皮膚への浸透性を高め、肌に
対して好ましい密着感があり、使用後肌面に膏体が残留
することがなく、かつ主薬成分、基剤成分が長期間変質
することがない。It has excellent stability, increases the permeability of the active ingredient into the skin, has a good adhesion to the skin, does not leave any paste on the skin after use, and maintains the active ingredient and base ingredient for a long time. It never changes in quality.
また、膏体の基剤成分として更にメチルビニルエーテル
無水マレイン酸コポリマー(商品名ガントレッツ、 G
、A、F社製)や有機酸等を添加して膏体全体の液性を
弱酸性に保持するときは、生薬成分の安定化が強化され
、また患部に対する刺激を軽減することができる。In addition, methyl vinyl ether maleic anhydride copolymer (trade name: GANTREZ, G
When maintaining the fluidity of the entire plaster at a weakly acidic level by adding organic acids, etc. (manufactured by companies A and F), the stabilization of the herbal medicine components is enhanced and irritation to the affected area can be reduced.
本発明は豚脂、ゴマ油、黄ロウを漢方処方に定められた
量で配合の範囲でする場合に特に有用である。The present invention is particularly useful when blending lard, sesame oil, and yellow wax in amounts prescribed in Chinese herbal medicine prescriptions.
また9本発明は、左突膏の薬効を本質的に損なわずに貼
付剤の剤形とした点に特徴があり。Furthermore, the present invention is characterized in that it is formulated into a patch without essentially impairing the medicinal efficacy of the left plaster.
用いられる成分として生薬のみに限定されるものではな
く、水、有機溶媒、含水有機溶媒による抽出エキス、生
薬より単離された精油や有効成分であってもよく、これ
らの全てを包含する。The ingredients used are not limited to only crude drugs, but may include water, organic solvents, extracts extracted with water-containing organic solvents, essential oils and active ingredients isolated from crude drugs, and include all of these.
鼓に抽出するための有機溶媒としてはメタノール、エタ
ノール等の低級アルコール、アセトン、酢酸エチル等の
極性溶媒、エーテル、ベンゼン、ヘキサン等の非極性有
機溶媒が挙げられる。また、生薬より単離された精油や
有効成分としては瀝膏に含まれるテレピン油、ロジン等
が挙げられる。Examples of organic solvents for extraction include lower alcohols such as methanol and ethanol, polar solvents such as acetone and ethyl acetate, and nonpolar organic solvents such as ether, benzene, and hexane. In addition, examples of essential oils and active ingredients isolated from crude drugs include turpentine oil and rosin contained in plasters.
また、既に確立された左突膏においては、その処方に用
いられる成分の配合比が定められており1本発明の漢方
処方左突膏の組成物は定められた配合比で製造すること
は勿論、その漢方処方の効用を損わない範囲内で適宜増
減し□た配合比で製造することもできる。In addition, in the already established Zuo-yume, the blending ratio of the ingredients used in its formulation is determined, and it goes without saying that the composition of the Chinese herbal formula of the present invention is manufactured using the predetermined blending ratio. It is also possible to manufacture the compound at a blending ratio that is appropriately increased or decreased within a range that does not impair the efficacy of the Chinese herbal prescription.
すなわち、ゴマ油1.000部に対し、黄ロウ750〜
850部の配合比が好ましい。That is, for 1.000 parts of sesame oil, 750 parts of yellow wax
A blending ratio of 850 parts is preferred.
漢方処方左突膏の組成物の主薬成分として生薬抽出エキ
スや生薬より単離された精油や有効成分を用いる場合の
その配合量は、生薬中の含有量より換算して求められた
量に基づいて適宜決定される。When crude drug extracts, essential oils or active ingredients isolated from crude drugs are used as the main drug ingredients in the composition of the Chinese herbal medicine prescription Zuotou-yun, the amount to be blended is based on the amount calculated from the content in the crude drug. It will be decided as appropriate.
なお、左突膏に用いられるゴマ油、黄ロウ。In addition, sesame oil and yellow wax are used for the left plaster.
豚脂等はそれ自身有用な薬効を有するものの、他の薬効
成分の軟膏基剤としての作用をも合わせもつものである
。従って、これらの成分は他の薬効成分すなわち、瀝膏
とは異なり。Although pork fat itself has useful medicinal properties, it also acts as an ointment base for other medicinal ingredients. Therefore, these ingredients are different from other medicinal ingredients, namely plasters.
比較的大きく配合比を変えても所期の目的を達成できる
。また、目的や必要によってはこれらの成分は適宜他の
同様の基剤と代替するこ゛とも、あるいは省くこともで
きる。 例えば。The desired purpose can be achieved even if the blending ratio is changed relatively significantly. Further, depending on the purpose and necessity, these components may be replaced with other similar base materials or may be omitted. for example.
左突膏の主薬成分として瀝膏より単離された精油や有効
成分を用いるときは、ゴマ油等の基剤成分を取り除いて
もそれ相応の薬効を奏するので2本発明のゝ漢方処方左
突膏の組成物−には、これらの外用漢方基剤を他の同様
の基剤で代替して、あるいは省いて配合した組成物も包
含される。When essential oils or active ingredients isolated from the plaster are used as the main medicinal ingredients of the plaster, the corresponding medicinal effects can be achieved even if the base ingredients such as sesame oil are removed. The compositions also include compositions in which these external herbal medicine bases are replaced with other similar bases or are omitted.
また、必要により従来鎮痛、消炎を目的とするパップ剤
の分野において汎用されているサリチル酸メチル、サリ
チル酸グリコール等のサリチル酸エステル類、力yフル
、メントール、ハツカ油、チモール、ノニル酸ワニリル
アミド。In addition, if necessary, salicylic acid esters such as methyl salicylate and glycol salicylate, which have been widely used in the field of poultices for the purpose of analgesia and anti-inflammation;
トウガラシエキス、ユーカリ油、ビタミンE。Capsicum extract, eucalyptus oil, vitamin E.
ビタミンEのエステル類、塩酸ジフェンヒドラミン等の
薬剤を、上記漢方処方左突膏の組成物に更に添加するこ
とは自由である。It is free to further add drugs such as vitamin E esters and diphenhydramine hydrochloride to the composition of the above-mentioned Chinese herbal prescription Zuo-tou-yun.
本発明における漢方処方左突膏の組成物の使用量は、貼
付基剤の種類等に応じて適宜選定されるが2通常前体全
量に対し1〜80重量%が好ましく、左突膏で定められ
た配合比で製造した組成物である場合は5〜50重量%
が好適である。The amount to be used of the composition of the Chinese herbal medicine formulation of the left plaster in the present invention is appropriately selected depending on the type of patch base, etc.2, but it is preferably 1 to 80% by weight based on the total amount of the preparation, and is determined by the left plaster. 5 to 50% by weight if the composition is manufactured with a blending ratio of
is suitable.
本発明において使用される親水性高分子どしては、アル
ギン酸ナトリウム、カルボキシメチルセルロースナトリ
ウム、ポリアクリル酸ナトリウム、カラギナン、カル゛
ボキシメチルセルロース、メチルビニルエーテル無水マ
レイン酸コポリマー、アルギン酸プロピレングリコ−茅
エステル、ヘクチン、サンサンガム、ローカストビンガ
ム、グアーガム、アラピアノガラクタン。Hydrophilic polymers used in the present invention include sodium alginate, sodium carboxymethyl cellulose, sodium polyacrylate, carrageenan, carboxymethyl cellulose, methyl vinyl ether maleic anhydride copolymer, propylene glyco-alginate ester, and hectin. , sunsan gum, locust bingham, guar gum, alapiano galactan.
ホリビニルアルコール、ポリビニルピロリドン。Holivinyl alcohol, polyvinylpyrrolidone.
カルボキシビニルポリマー(カーボホ−# ) 等が挙
げられ、とりわけアルギン酸−ナトリウム。carboxyvinyl polymers (carbopho-#) and the like, especially sodium alginate.
カルボキシメチルセルロースナトリウム、ポリアクリル
酸ナトリウム、カラギナン、カルボキシメチルセルロー
ス、メチルビニルエーテル無水マレイン酸コポリマーが
好ましい。Preferred are sodium carboxymethyl cellulose, sodium polyacrylate, carrageenan, carboxymethyl cellulose, and methyl vinyl ether maleic anhydride copolymers.
これらの親水性高分子は単独又は二種以上を適宜の割合
で配合して用いることもできる。親水性高分子の使用量
は用いられる親水性高分子の種類や漢方処方左突膏の組
成物の使用量等を考慮して適宜選択する必要があるが2
通常前体全量に対し0.1〜25重量%、殊に0.5〜
15重量の範囲内が適切である。親水性高分子として二
種類以上の混合物を用いる場合、その使用量はその総量
として上記範囲内にあればよい。These hydrophilic polymers can be used alone or in combination of two or more in an appropriate ratio. The amount of hydrophilic polymer to be used needs to be selected appropriately, taking into account the type of hydrophilic polymer used and the amount of the composition of the Chinese herbal medicine prescription left plaster.
Usually 0.1 to 25% by weight, especially 0.5 to 25% by weight based on the total amount of the precursor
A range of 15 weight is appropriate. When using a mixture of two or more types of hydrophilic polymers, the total amount used may be within the above range.
また、天然又は合成ゴムは、天然物より得られた生ゴム
やS、 B、 Rゴム等の合成ゴムは勿論のこと、これ
らを用いたラテックスエマルジョンをも意味する。ラテ
ックスエマルジョンは1通常ゴム含有率40〜70%程
度のものが用いられる。Furthermore, natural or synthetic rubber refers not only to raw rubber obtained from natural products and synthetic rubber such as S, B, and R rubber, but also to latex emulsions using these rubbers. The latex emulsion used usually has a rubber content of about 40 to 70%.
天然又は合成ゴムの使用量は用いられる漢方処方左突膏
の組成物の使用量等を考慮して適宜決定されるが、膏体
全量に対し1.0〜40重量%。The amount of natural or synthetic rubber to be used is appropriately determined in consideration of the amount of the composition of the Chinese herbal medicine formulation Zuobutsu plaster used, but it is 1.0 to 40% by weight based on the total amount of the plaster.
殊に2.0〜25重量の範囲内が好適である。In particular, a range of 2.0 to 25 weight is preferred.
また、界面活性剤としては、ポリオキレエチレン高級脂
肪酸エステル、ポリオキシェチレジソルビタン高級脂肪
酸エステル、ソルビタン高級脂肪酸エステル、ポリオキ
シエチレンヒマシ油誘導体、ポリオキシエチレン硬化ヒ
マシ油誘導体、ポリオキシエチレン高級アルコールエー
テル、ポリオキシエチレンアルキルアリールエーテル等
が挙げられ、殊にポリオキシエチレンンルビタンモノス
テアレート、ポリオキシエチレンソルビタンモノパルミ
テート等のポリオキシエチレンソルビタン高級脂肪酸エ
ステル(商品名ツイーン)やソルビタンモノステアレー
ト。In addition, as surfactants, polyoxyethylene higher fatty acid ester, polyoxyethyledisorbitan higher fatty acid ester, sorbitan higher fatty acid ester, polyoxyethylene castor oil derivative, polyoxyethylene hydrogenated castor oil derivative, polyoxyethylene higher alcohol Examples include ether, polyoxyethylene alkylaryl ether, etc., especially polyoxyethylene sorbitan higher fatty acid esters (trade name: Tween) such as polyoxyethylene rubitan monostearate, polyoxyethylene sorbitan monopalmitate, and sorbitan monostearate. .
ンルビタンセスキオレート等のソルビタン高級脂肪酸エ
ステル(商品名スパン)が好ましい。Sorbitan higher fatty acid esters (trade name: Span) such as nrubitan sesquiolate are preferred.
界面活性剤の使用量は漢方処方左突膏の組成物の使用量
等に応じて適宜選択すればよく、およそ0,2〜10重
量%、好ましくは0.5〜5重量%である。The amount of the surfactant to be used may be appropriately selected depending on the amount of the composition of the Chinese herbal medicine prescription Zuotouyin, etc., and is approximately 0.2 to 10% by weight, preferably 0.5 to 5% by weight.
膏体全体の液性を弱酸性に保持させるものとしては、有
機酸の他、酸性側のpHをもつ高分子物質例えばメチル
ビニルエーテル無水マレイン酸コポリマー(商品名 ガ
ントレッツ)やカルボキシビニルポリマー(商品名 カ
ーボポール)を用いることもできる。In addition to organic acids, polymeric substances with an acidic pH such as methyl vinyl ether maleic anhydride copolymer (product name: GANTREZ) and carboxyvinyl polymer (product name: CARBON) are used to maintain the liquid properties of the entire plaster to be weakly acidic. pole) can also be used.
有機酸はそれ自身貼付基剤として特性を有するがpH調
整剤をも兼ねるものである。かかる有機酸としては酢酸
、コハク酸、クエン酸、リンゴ酸、フマール酸、マレイ
ン酸、酒石酸等が挙げられる。The organic acid itself has properties as a patch base, but also serves as a pH adjuster. Such organic acids include acetic acid, succinic acid, citric acid, malic acid, fumaric acid, maleic acid, tartaric acid, and the like.
本発明の左突膏の貼付剤を製造するには、(1)先ず左
突膏に用いられる諸成分をそのまま、(2)若しくは瀝
膏のゴマ油抽出物と、ミツロウ、豚脂とを、又は(3)
外用漢方処方に定められた方法に従って予じめ左突膏の
製剤を調製し;貼付基剤に配合し、均一に練合して膏体
とする。To produce the plaster patch of the present invention, (1) first use the ingredients used in the plaster as they are, (2) or add sesame oil extract of the plaster, beeswax, pork fat, or (3)
A preparation of the left patch is prepared in advance according to the method prescribed in the Chinese herbal prescription for external use; it is mixed into a patch base and kneaded uniformly to form a paste.
貼付基剤としては、前記親水性高分子、天然又は合成ゴ
ム、界面活性剤、その他の薬効成分の他、ゼラチン、水
や、必要により粉末賦形剤。The adhesive base includes the hydrophilic polymer, natural or synthetic rubber, surfactant, other medicinal ingredients, gelatin, water, and powder excipients if necessary.
酸化防止剤、軟化剤、収斂剤、その他の基剤が用いられ
る。Antioxidants, emollients, astringents, and other base agents are used.
絃に、粉末賦形剤としてはカオリン、ベントナイト、酸
化亜鉛、酸化チタン、合成ケイ酸アルミニウム等が、酸
化防止剤としてはグアヤコールエステル類、ブチルヒド
ロオキシアニソール、ジブチルヒドロキシトルエン、ノ
ルジヒドログアイアレチン酸等が、軟化剤としては流動
パラフィン、シリコン、植物油、高級脂肪酸エステル等
が、収斂剤としては塩化アルミニウム。For the strings, powder excipients include kaolin, bentonite, zinc oxide, titanium oxide, synthetic aluminum silicate, etc., and antioxidants include guaiacol esters, butylhydroxyanisole, dibutylhydroxytoluene, nordihydroguaiaretic acid. Liquid paraffin, silicone, vegetable oil, higher fatty acid ester, etc. are used as softeners, and aluminum chloride is used as an astringent.
硫酸アルミニウム、ミョウバン等の三価の金属イオンを
生成する塩等が、その他の基剤としてはポリブテン、ア
ラビアゴム、エステルガム等の粘着剤、アルカリ土類金
属塩、多価アルコール等の保湿剤、メチルパラベン、エ
チルパラベン等の防腐剤等が挙げられる。Salts that generate trivalent metal ions such as aluminum sulfate and alum, etc., and other bases include adhesives such as polybutene, gum arabic and ester gum, humectants such as alkaline earth metal salts and polyhydric alcohols, Examples include preservatives such as methylparaben and ethylparaben.
瀝膏に含まれるロジンは粘着剤としての作用を有してお
り、またチモールは防腐剤を兼ねることができる。The rosin contained in the plaster acts as an adhesive, and the thymol can also serve as a preservative.
これらの基剤は得られる膏体の特性を考慮して適当量用
いられる。These bases are used in appropriate amounts in consideration of the properties of the resulting paste.
また1本発明貼付剤膏体を製造するに際しては2機械釣
線合操作を容易にするため、用いられる基剤の物理化学
的性状を考慮して添加練合順序を設定し、あるいは加温
処理することは自由である。In addition, when manufacturing the adhesive patch of the present invention, the order of addition and kneading should be set in consideration of the physicochemical properties of the base used, or heating treatment should be carried out in order to facilitate the machine balancing operation. You are free to do what you want.
次いでこのようにして得られた膏体を適宜の温度に保持
したまま支持体上に展延塗布し、更にその上に剥離被覆
物を貼合し、適宜の大きさに裁断する。支持体は布地、
不織布9紙1合成樹脂膜などが用いられ、殊にネル等の
起毛布が好ましい。また、剥離被覆物としてはポリエチ
レン、セロファンやプラスチックフィルム等が挙げられ
る。Next, the paste thus obtained is spread and coated onto a support while being maintained at an appropriate temperature, a release coating is further laminated thereon, and the paste is cut into an appropriate size. The support is fabric,
A non-woven fabric, 9 paper, 1 synthetic resin film, etc. are used, and a raised fabric such as flannel is particularly preferred. Examples of release coatings include polyethylene, cellophane, and plastic films.
なお9本発明の技術はゴム膏にも応用できるものであり
1本発明は親水性プラスターのみに限定されるものでは
なく、硬骨の形態の貼付薬をも包含する。Note that the technology of the present invention can also be applied to rubber plasters, and the present invention is not limited only to hydrophilic plasters, but also includes plasters in the form of bone.
以下に実施例を掲記し1本発明を更に詳細に説明する。EXAMPLES The present invention will be explained in more detail by way of examples below.
なお、左突膏を予め調製した後、貼付基剤と配合して本
発明の貼付剤とする方法において。In addition, in the method of preparing the patch of the present invention by preparing the plaster in advance and then blending it with a patch base.
左突膏の組成物は以下の方法によって製造した。The composition of the left plaster was manufactured by the following method.
左突膏
ゴマ油1,000部をよく煮て水分を蒸発させ、これに
ミツロウ220部、豚脂58部を入れて溶かし。Boil 1,000 parts of sesame oil well to evaporate the water, then add 220 parts of beeswax and 58 parts of pork fat and dissolve.
次いで瀝膏800部を入れて溶かし、布で濾過し。Next, add 800 parts of plaster, dissolve, and filter through a cloth.
更に煮て粘稠性を高め、攪拌しながら冷却して均一な軟
膏を得る。Boil further to increase the consistency and cool while stirring to obtain a homogeneous ointment.
実施例 1、
精製水200部にクエン酸0.2部を溶解し、カオリン
25゜0部、酸化亜鉛0.1部、酸化チタン0.5部。Example 1: Dissolve 0.2 parts of citric acid in 200 parts of purified water, add 25.0 parts of kaolin, 0.1 part of zinc oxide, and 0.5 parts of titanium oxide.
ゼラチン5.0部、アルギン酸ナトリウム1.5部、及
びグリセリン15,0部を添加して練合し、これに精製
水9,4部にメチルビニルエーテル無水マレイン酸コポ
リマー2.0部を溶解したものを添加して練合し、これ
に別途予め調製した左突膏10.0部と、流動パラフィ
ン5.0部、ポリオキシエチレンソルビタンモノステア
レート(ツイーン60 ) 0.5部、天然ゴムラテッ
クス4.0部、 S、 B、 R,ラテックス0゜5
部、ポリブテン1,0部及び酸化防止剤、防腐剤をそれ
ぞれ微量添加し、50℃で均一に練合した後、ネルに展
延し、その表面にプラスチックフィルムを貼合して、所
定の大きさに裁断する。5.0 parts of gelatin, 1.5 parts of sodium alginate, and 15.0 parts of glycerin were added and kneaded, and 2.0 parts of methyl vinyl ether maleic anhydride copolymer was dissolved in 9.4 parts of purified water. To this were added 10.0 parts of left plaster prepared separately in advance, 5.0 parts of liquid paraffin, 0.5 parts of polyoxyethylene sorbitan monostearate (Tween 60), and 4 parts of natural rubber latex. .0 parts, S, B, R, latex 0°5
1.0 parts of polybutene, an antioxidant, and a preservative are added in small amounts, and after uniformly kneading at 50°C, it is spread on a flannel, and a plastic film is pasted on the surface to give it a predetermined size. Cut it right.
実施例2゜
実施例1と同様にして左突膏30%を含む左突膏貼付剤
を製造した。Example 2 A left plaster patch containing 30% left plaster was produced in the same manner as in Example 1.
Claims (7)
170〜270部、豚脂50〜70部及び瀝膏750〜
850部である。特許請求の範囲第(1)項記載の貼付
剤(2) The Chinese herbal prescription composition contains 1,000 parts of sesame oil, 170 to 270 parts of yellow wax, 50 to 70 parts of pork fat, and 750 parts of plaster.
850 copies. Patch according to claim (1)
る特許請求の範囲第(1)項記載の貼付剤(3) The patch according to claim (1), which contains the composition of a Chinese herbal medicine formulation and a patch base.
からなる群より選択された1種以上、又はこれに更に界
面活性剤を加えたものを含有する特許請求の範囲第(1
)項又は(3)項記載の貼付剤(4) The patch base contains one or more selected from the group consisting of hydrophilic polymers, natural rubber, and synthetic rubber, or a surfactant added thereto.
) or the patch described in (3)
又は漢方処方に基づいて調製した左突膏を、貼布基剤に
配合し、均一に練合し得られた膏体を支持体上に展延塗
布することを特徴とする漢方処方の左突膏組成物を含有
する貼付剤の製造法(5) Sesame oil, yellow wax, and pork fat, which are the ingredients of left paste,
Or, a left patch with a Chinese herbal prescription, which is characterized in that a left patch prepared based on a Chinese herbal prescription is blended into a patch base, kneaded uniformly, and the resulting paste is spread and applied on a support. Method for producing a patch containing a plaster composition
170〜270部、豚脂50〜70部及び瀝膏750〜
850部である特許請求の範囲第(5)項記載の製造法(6) The Chinese herbal prescription composition contains 1,000 parts of sesame oil, 170 to 270 parts of yellow wax, 50 to 70 parts of pork fat, and 750 parts of plaster.
850 copies of the manufacturing method according to claim (5)
からなる群より選択された1種以上、又はこれにさらに
界面活性剤を加えたものを必須成分とする特許請求の範
囲第(5)項記載の製造法(7) The patch base has as an essential component one or more selected from the group consisting of hydrophilic polymers, natural rubber, and synthetic rubber, or a surfactant further added thereto. Manufacturing method described in section 5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63284592A JPH01151524A (en) | 1988-11-10 | 1988-11-10 | 'satotsu-ko' poultice and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63284592A JPH01151524A (en) | 1988-11-10 | 1988-11-10 | 'satotsu-ko' poultice and preparation thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56183387A Division JPS5885817A (en) | 1981-11-16 | 1981-11-16 | Herb plaster for external application |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01151524A true JPH01151524A (en) | 1989-06-14 |
Family
ID=17680450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63284592A Pending JPH01151524A (en) | 1988-11-10 | 1988-11-10 | 'satotsu-ko' poultice and preparation thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01151524A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008508954A (en) * | 2004-08-05 | 2008-03-27 | コリウム インターナショナル, インコーポレイテッド | Adhesive composition |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US9084723B2 (en) | 2001-05-01 | 2015-07-21 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions with an erodible backing member |
US9089481B2 (en) | 2001-05-01 | 2015-07-28 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US9127140B2 (en) | 2001-05-01 | 2015-09-08 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Water-absorbent adhesive compositions and associated methods of manufacture and use |
USRE45666E1 (en) | 2000-07-07 | 2015-09-08 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US9144552B2 (en) | 2004-01-30 | 2015-09-29 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Rapidly dissolving film for delivery of an active agent |
US9259504B2 (en) | 2001-05-01 | 2016-02-16 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Non-electrically conductive hydrogel composition |
US9610253B2 (en) | 2009-01-14 | 2017-04-04 | Corium International, Inc. | Transdermal administration of tamsulosin |
JPWO2016103999A1 (en) * | 2014-12-26 | 2017-10-05 | ニチバン株式会社 | Packaging for patch and packaging method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5520715A (en) * | 1978-07-31 | 1980-02-14 | Lion Corp | Poultice |
JPS5545626A (en) * | 1978-09-26 | 1980-03-31 | Lion Corp | Poultice |
JPS5579318A (en) * | 1978-12-07 | 1980-06-14 | Taisho Pharmaceut Co Ltd | Poultice |
-
1988
- 1988-11-10 JP JP63284592A patent/JPH01151524A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5520715A (en) * | 1978-07-31 | 1980-02-14 | Lion Corp | Poultice |
JPS5545626A (en) * | 1978-09-26 | 1980-03-31 | Lion Corp | Poultice |
JPS5579318A (en) * | 1978-12-07 | 1980-06-14 | Taisho Pharmaceut Co Ltd | Poultice |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE45666E1 (en) | 2000-07-07 | 2015-09-08 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US9532935B2 (en) | 2001-05-01 | 2017-01-03 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US10835454B2 (en) | 2001-05-01 | 2020-11-17 | Corium, Inc. | Hydrogel compositions with an erodible backing member |
US9089481B2 (en) | 2001-05-01 | 2015-07-28 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US9127140B2 (en) | 2001-05-01 | 2015-09-08 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US9084723B2 (en) | 2001-05-01 | 2015-07-21 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions with an erodible backing member |
US9259504B2 (en) | 2001-05-01 | 2016-02-16 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Non-electrically conductive hydrogel composition |
US9687428B2 (en) | 2001-05-01 | 2017-06-27 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US10869947B2 (en) | 2001-05-01 | 2020-12-22 | Corium, Inc. | Hydrogel compositions |
US10179096B2 (en) | 2001-05-01 | 2019-01-15 | Corium International, Inc. | Hydrogel compositions for tooth whitening |
US9144552B2 (en) | 2004-01-30 | 2015-09-29 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Rapidly dissolving film for delivery of an active agent |
JP2008508954A (en) * | 2004-08-05 | 2008-03-27 | コリウム インターナショナル, インコーポレイテッド | Adhesive composition |
US9610253B2 (en) | 2009-01-14 | 2017-04-04 | Corium International, Inc. | Transdermal administration of tamsulosin |
US10238612B2 (en) | 2009-01-14 | 2019-03-26 | Corium International, Inc. | Transdermal administration of tamsulosin |
JPWO2016103999A1 (en) * | 2014-12-26 | 2017-10-05 | ニチバン株式会社 | Packaging for patch and packaging method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5694665B2 (en) | Topical preparation and its usage | |
DE69815263T2 (en) | STABLE PREPARATION BASED ON ACETYLSALICYLIC ACID FOR EXTERNAL USE | |
JP4361867B2 (en) | Skin external preparation composition for prevention and treatment of acne | |
JPH01151524A (en) | 'satotsu-ko' poultice and preparation thereof | |
JPH08188527A (en) | Sheet-like pack agent | |
WO2004110428A1 (en) | Anti-inflammatory analgesic adhesive patch | |
JP4677063B2 (en) | Dutch mustard extract combination external preparation | |
JPS6351126B2 (en) | ||
JPS61275212A (en) | Ketoprofen-containing poultice | |
JPH01151523A (en) | 'shiun-ko' poultice and preparation thereof | |
JPH05201879A (en) | Percutaneous administration pharmaceutical | |
JP4575632B2 (en) | Drugs for migraine relief | |
JPS6034924B2 (en) | Poultice and its manufacturing method | |
JPS5885817A (en) | Herb plaster for external application | |
JP7440931B2 (en) | Chinese herbal medicine gel composition and its preparation method and use | |
JPH05139928A (en) | Melanin suppressing poultice | |
JP2005075755A (en) | Antiphlogistic-sedative plaster and method for producing the same | |
JPS59193817A (en) | Pharmaceutical preparation for external use | |
JPS59130811A (en) | Plaster base for pharmaceutical preparation of adherent application | |
JP2008231081A (en) | Ketoprofen-containing external preparation | |
JP3612731B2 (en) | Anti-inflammatory analgesic topical | |
JPS5855429A (en) | Adhesive remedy for dermatopathy | |
JP2793278B2 (en) | Crude drug patch preparation | |
JP2024055826A (en) | Pharmaceutical composition containing loxoprofen or its salt and salicylic acid | |
JPS6115845A (en) | Shellac-containing composition for epidermis |